Clinical Trial Update: Fenofibrate and Omega-3 Fatty Acid Modulation of Endotoxemia [NA]

View source ↗

Summary

A completed clinical trial evaluating fenofibrate in combination with omega-3 fatty acids for modulation of endotoxemia in cardiovascular disease; results were …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• FENOFIBRATE (Fenofibrate)
• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: University of Pennsylvania | Conditions: Cardiovascular Disease | NA | Status: COMPLETED | Results posted: 2016-02-19